Hematologic Diseases clinical trials
The registry lists 457 studies for Hematologic Diseases across more than 10 countries. 107 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-09-24.
Status
- Completed
- 222
- Recruiting
- 70
- Status unknown
- 46
- Terminated
- 32
- Active, not recruiting
- 32
- Not yet recruiting
- 26
Phase
- Phase 2
- 106
- Phase 3
- 60
- Phase 1
- 59
- Phase 4
- 13
- Early Phase 1
- 6
Where
- United States
- 189
- France
- 58
- China
- 56
- Italy
- 54
- Germany
- 42
- United Kingdom
- 40
Who runs them
National Heart, Lung, and Blood Institute (NHLBI) (39) · M.D. Anderson Cancer Center (10) · Assiut University (9) · Nanfang Hospital, Southern Medical University (7) · Assistance Publique - Hôpitaux de Paris (7) · Masonic Cancer Center, University of Minnesota (7) · Novartis Pharmaceuticals (6) · Vertex Pharmaceuticals Incorporated (6)
Studies
Recruiting first, then most recently updated. Showing 50 of 457 — search for more.
- Multidisciplinary Intervention for Adults With Chronic Graft-versus-host DiseaseRecruitingNCT06910969Not applicable1 country
- Treatment of Hemophilia A Patients With FVIII InhibitorsRecruitingNCT040230192 countries
- Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic LeukemiaRecruitingNCT07504458Phase 35 countries
- Screening for Hematology Branch ProtocolsEnrolling by invitationNCT000016201 country
- A Study of Mezagitamab in Adults With Chronic Primary Immune ThrombocytopeniaRecruitingNCT06722235Phase 318 countries
- Data Collection of Standard Care and Evaluation of NHLBI Patients and DonorsEnrolling by invitationNCT044509271 country
- A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)RecruitingNCT06439082Phase 35 countries
- (Apex) Bezuclastinib in Patients With Advanced Systemic MastocytosisRecruitingNCT04996875Phase 214 countries
- A Study Investigating Intravenous Human Normal Immunoglobulin 10% in Adults With Chronic Immune Thrombocytopenia (ITP)RecruitingNCT07059000Phase 38 countries
- Study to Characterize Mismatched to Fully HLA-Matched Ossium HPC, Marrow and Living Donor Transplantation in Patients With Hematologic MalignanciesNot yet recruitingNCT07710781Not applicable
- A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune ThrombocytopeniaRecruitingNCT06948318Phase 315 countries
- Alpha/Beta T-cell Depleted Blood-forming Stem Cell Transplant From Related or Unrelated Donors for Blood Diseases in Children and Young AdultsNot yet recruitingNCT04806347Phase 1
- Immersive Virtual Reality Applied to Therapeutic Physical Exercise in Cellular TherapyNot yet recruitingNCT07679958Not applicable1 country
- Harmony-HHT: ATV-1601 in Participants With Hereditary Hemorrhagic Telangiectasia (HHT)RecruitingNCT07601425Phase 1/21 country
- A Dietitian-Driven Unified Nutritional Care Model (ADDUCE)RecruitingNCT07730996Not applicable1 country
- A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple MyelomaRecruitingNCT07075185Phase 12 countries
- Reconstruction Kinetics of γδ T Cells After Unrelated Cord Blood TransplantationRecruitingNCT077826841 country
- Visual and Auditory Distraction for the Relief of Pain and AnxietyEnrolling by invitationNCT07023692Not applicable1 country
- ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic DisordersRecruitingNCT043986281 country
- A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)RecruitingNCT05254743Phase 323 countries
- Efficacy and Safety of SIL-8301 for Control of Hemolysis in a Uniform Sickle Cell Disease EndotypeRecruitingNCT07282210Phase 21 country
- A Long-term Follow-up Study in Participants Who Received CTX001Enrolling by invitationNCT04208529Phase 36 countries
- A Phase 1/2 Study to Evaluate the Safety and Efficacy of Dibotatug (DR-01) in Adults With Bone Marrow Failure SyndromesNot yet recruitingNCT07712562Phase 1/21 country
- Bispecific CD19/CD20-Targeted Chimeric Antigen Receptor (CAR) Modified T Cells With 4-1BB and Mutated CD28 Costimulatory Domains in Patients With Relapsed or Refractory CD19+ Hematologic MalignanciesNot yet recruitingNCT07701889Phase 11 country
- Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic SyndromeRecruitingNCT07216443Phase 21 country
- Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)RecruitingNCT01666080Not applicable1 country
- Role of Viscoelastometric Testing in the Development and Validation of a Clinical-biological Score for Predicting Bleeding in Patients With Malignant Haematological Disorders and Severe ThrombocytopeniaNot yet recruitingNCT07653672
- Human Leukocyte Antigen (HLA) Mismatched Unrelated Allogeneic Hematopoietic Stem Cell TransplantationRecruitingNCT06809712Phase 11 country
- Frailty in the Elderly Oncological and Oncohematological Patient.Enrolling by invitationNCT076243701 country
- Therapeutic RSK1 Targeting in MyelofibrosisRecruitingNCT07379125Phase 11 country
- CHAPTER: Clonal Haematopoiesis Assessment: Prevention, Treatment and ResearchRecruitingNCT073130591 country
- The Implementation of the Go Wish Game to Promote Advance Care Planning in Onco- Hematologic DiseaseRecruitingNCT06795815Not applicable1 country
- Fertility in Young Adults Who Did (Not) Store Testicular Tissue Before a Treatment Leading to Fertility ProblemsEnrolling by invitationNCT04202094Not applicable1 country
- Amphotericin B for Breakthrough Fungal Infections After Triazole Prophylaxis in Hematological PatientsNot yet recruitingNCT07559032Not applicable1 country
- A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)RecruitingNCT04256317Phase 2/310 countries
- Autologous Testicular Tissue TransplantationRecruitingNCT05414045Not applicable1 country
- Complementary and Alternative Medicine Among Patients With Hematologic Malignancies in FranceNot yet recruitingNCT07541326Not applicable1 country
- ATHNdataset RegistryRecruitingNCT068205151 country
- Diamond Blackfan Anemia Registry (DBAR)RecruitingNCT001060151 country
- Early Use of Tacrolimus in HLA-Mismatched Haploidentical Allogeneic Hematopoietic Transplantation With Post-Transplant CyclophosphamideRecruitingNCT06828796Phase 21 country
- Open-Label Extension Study to Pioneer Study 6058-SCD-101Enrolling by invitationNCT07401823Phase 21 country
- Collection of Immunology Specimens From Patients With Cancer or Blood Disorders, and Healthy VolunteersRecruitingNCT032078541 country
- Detection of Parasitic Infections in Patients With Haematological Disorders in Assiut University HospitalsNot yet recruitingNCT07496827
- Efficacy and Safety of Lusutrombopag After Allogeneic Hematopoietic Stem Cell TransplantationRecruitingNCT07483385Not applicable1 country
- Clonal Hematopoiesis of Immunological SignificanceNot yet recruitingNCT059698211 country
- Evaluation of Efficacy and Safety of a Single Dose of CTX001 in Participants With Transfusion-Dependent β-Thalassemia and Severe Sickle Cell DiseaseRecruitingNCT05477563Phase 34 countries
- Phase I Study of CTL Anti-DP Infusion Post-hematopoietic Stem Cell TransplantationRecruitingNCT04180059Phase 11 country
- Advancing Health Information Exchange (HIE) During Inter-hospital Transfer (IHT) to Improve Patient OutcomesEnrolling by invitationNCT05443321Not applicable1 country
- A Long-Term Follow-Up Study in Severe Hemophilia A Subjects Who Received BMN 270 in a Prior BioMarin Clinical Trial (270-401)Enrolling by invitationNCT0576838612 countries
- Stem Cell Transplant From Donors After Alpha Beta Cell Depletion in Children and Adults With T-allo10 Cells AddbackRecruitingNCT04640987Phase 11 country